Education
About Us
Working with TipRanks
Follow Us
Aardvark Therapeutics, Inc. (AARD)
NASDAQ:AARD
AARD Analyst Ratings
Moderate Buy
6 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AARD Stock 12 Month Forecast
Average Price Target
$18.88
▲(270.92% Upside)
| Highest Price Target$45.00 | Average Price Target$18.88 | Lowest Price Target$6.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
―
Hold
―
Downgraded
03/02/26
Cantor Fitzgerald
$50→$45
Buy
784.09%
Upside
Reiterated
03/02/26
BTIG
$26→$9
Buy
76.82%
Upside
Reiterated
03/02/26
William Blair
―
Buy
―
Reiterated
03/02/26
Morgan Stanley
$7
Hold
37.52%
Upside
Downgraded
03/02/26
Stifel Nicolaus
$24→$6
Hold
17.88%
Upside
Downgraded
03/02/26
RBC Capital
$18→$6
Hold
17.88%
Upside
Downgraded
03/01/26
Oppenheimer
$35→$21
Buy
312.57%
Upside
Reiterated
02/27/26
B. Riley Securities
$32
Buy
528.68%
Upside
Initiated
01/28/26
Bank of America Securities
$25
Buy
391.16%
Upside
Reiterated
12/18/25
Raymond James
$47
Buy
823.38%
Upside
Initiated
12/02/25
JonesTrading
$33
Buy
548.33%
Upside
Initiated
09/30/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
―
Hold
―
Downgraded
03/02/26
Cantor Fitzgerald
$50→$45
Buy
784.09%
Upside
Reiterated
03/02/26
BTIG
$26→$9
Buy
76.82%
Upside
Reiterated
03/02/26
William Blair
―
Buy
―
Reiterated
03/02/26
Morgan Stanley
$7
Hold
37.52%
Upside
Downgraded
03/02/26
Stifel Nicolaus
$24→$6
Hold
17.88%
Upside
Downgraded
03/02/26
RBC Capital
$18→$6
Hold
17.88%
Upside
Downgraded
03/01/26
Oppenheimer
$35→$21
Buy
312.57%
Upside
Reiterated
02/27/26
B. Riley Securities
$32
Buy
528.68%
Upside
Initiated
01/28/26
Bank of America Securities
$25
Buy
391.16%
Upside
Reiterated
12/18/25
Raymond James
$47
Buy
823.38%
Upside
Initiated
12/02/25
JonesTrading
$33
Buy
548.33%
Upside
Initiated
09/30/25
Best Analysts Covering Aardvark Therapeutics, Inc.
3 Months
xxx
Success Rate
4/6 ratings generated profit
Average Return
+7.17%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +7.17% per trade.
1 Year
Success Rate
0/5 ratings generated profit
Average Return
-38.56%
reiterated a buy rating 14 days ago
Copying Joshua Schimmer's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -38.56% per trade.
2 Years
xxx
Success Rate
0/5 ratings generated profit
Average Return
-39.92%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -39.92% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AARD Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
18
18
16
11
7
Buy
0
1
3
5
5
Hold
0
1
11
21
23
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
20
30
37
35
Each month's total comprises the sum of three months' worth of ratings.
AARD Financial Forecast
AARD Stock Forecast FAQ
What is AARD’s average 12-month price target, according to analysts?
Based on analyst ratings, Aardvark Therapeutics, Inc.’s 12-month average price target is 18.88.
What is AARD’s upside potential, based on the analysts’ average price target?
Aardvark Therapeutics, Inc. has 270.92% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AARD a Buy, Sell or Hold?
Aardvark Therapeutics, Inc. has a consensus rating of Moderate Buy which is based on 6 buy ratings, 4 hold ratings and 0 sell ratings.
What is Aardvark Therapeutics, Inc.’s price target?
The average price target for Aardvark Therapeutics, Inc. is 18.88. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $45.00 ,the lowest forecast is $6.00. The average price target represents 270.92% Increase from the current price of $5.09.
The highest analyst price target is $45.00 ,the lowest forecast is $6.00. The average price target represents 270.92% Increase from the current price of $5.09.
What do analysts say about Aardvark Therapeutics, Inc.?
Aardvark Therapeutics, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of AARD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.